Mitochondrial TrxR2 regulates metabolism and protects from metabolic disease through enhanced TCA and ETC function

Commun Biol. 2022 May 16;5(1):467. doi: 10.1038/s42003-022-03405-w.

Abstract

Mitochondrial dysfunction is a key driver of diabetes and other metabolic diseases. Mitochondrial redox state is highly impactful to metabolic function but the mechanism driving this is unclear. We generated a transgenic mouse which overexpressed the redox enzyme Thioredoxin Reductase 2 (TrxR2), the rate limiting enzyme in the mitochondrial thioredoxin system. We found augmentation of TrxR2 to enhance metabolism in mice under a normal diet and to increase resistance to high-fat diet induced metabolic dysfunction by both increasing glucose tolerance and decreasing fat deposition. We show this to be caused by increased mitochondrial function which is driven at least in part by enhancements to the tricarboxylic acid cycle and electron transport chain function. Our findings demonstrate a role for TrxR2 and mitochondrial thioredoxin as metabolic regulators and show a critical role for redox enzymes in controlling functionality of key mitochondrial metabolic systems.

MeSH terms

  • Animals
  • Citric Acid Cycle / physiology
  • Electron Transport / physiology
  • Metabolic Diseases* / genetics
  • Metabolic Diseases* / metabolism
  • Mice
  • Mitochondria / metabolism
  • Oxidation-Reduction
  • Thioredoxin Reductase 2* / genetics
  • Thioredoxin Reductase 2* / metabolism
  • Thioredoxins / genetics
  • Thioredoxins / metabolism

Substances

  • Thioredoxin Reductase 2
  • Thioredoxins
  • Txnrd2 protein, mouse

Associated data

  • Dryad/10.5061/dryad.fttdz08vk